Intersect Capital’s Harte-Hanks HHS Stock Holding History

Intersect Capital’s Portfolio HHS Stock Details HHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-190	Closed	-$13K	–	217
2015 Q1	$13K	Hold	190	–	–	0.01%	305
2014 Q4	$15K	Buy	+190	New	+$12.4K	0.01%	309

Other funds holding HHS

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

RFC

Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return

Intersect Capital's HHS Position: Q2 2015 in Review

Intersect Capital sold out of Harte-Hanks (HHS) in Q2 2015, closing a stake of 190 shares — an estimated $13K sold.

Intersect Capital first reported a position in HHS in Q4 2014 and held it in 2 quarters. The position peaked at $15K in Q4 2014. 121 funds tracked by Wall St. Rank hold HHS as of Q2 2015.

Intersect Capital reported no remaining Harte-Hanks position as of Q2 2015 after selling out during the quarter.
Intersect Capital sold 190 Harte-Hanks shares in Q2 2015, an estimated $13K.
Intersect Capital first reported a position in Harte-Hanks in Q4 2014 and held it in 2 quarters.
Intersect Capital's Harte-Hanks position peaked at $15K in Q4 2014.
121 funds tracked by Wall St. Rank held Harte-Hanks as of Q2 2015.

Based on Intersect Capital's 13F filing for Q2 2015, filed 3 Aug 2015.